IDEXX LABORATORIES INC /DE (IDXX) Deferred Tax Assets, Net of Valuation Allowance USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Idexx Laboratories Inc /De quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from 2016 to 2023.
  • Idexx Laboratories Inc /De Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $212 M, a 46.6% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $212 M +$67.3 M +46.6% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $144 M +$21.9 M +17.8% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $123 M +$30 K +0.02% Dec 31, 2021 10-K 2023-02-16
Q4 2020 $123 M +$65.5 M +115% Dec 31, 2020 10-K 2022-02-16
Q4 2019 $57.1 M +$2.34 M +4.28% Dec 31, 2019 10-K 2021-02-12
Q4 2018 $54.7 M +$5.72 M +11.7% Dec 31, 2018 10-K 2020-02-14
Q4 2017 $49 M -$7.75 M -13.7% Dec 31, 2017 10-K 2019-02-15
Q4 2016 $56.7 M Dec 31, 2016 10-K 2018-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.